Emerging Business Models in Biopharma - Drug Discovery TOE

Emerging Business Models in Biopharma - Drug Discovery TOE

RELEASE DATE
08-Jul-2016
REGION
Global
Research Code: D951-00-07-00-00
SKU: HC02798-GL-TA_19692

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC02798-GL-TA_19692

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across emerging business models in the biopharmaceutical industry. The corresponding patent scenario is depicted, along with the industry interactions..

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Biopharma, proof of concept model, lean innovation model, outcome focused model, collaborative business model

Table of Contents

Trend Overview

  • Emerging Business Models in Biopharma
  • Emerging Business Models in Biopharma

Technology Profiles

  • Proof of Concept Model
  • Value Enabling Model
  • Lean Innovation Model
  • Outcome Focused Model
  • Collaborative Business Model
  • Outcome Focused Model
  • Collaborative Business Model

Strategic Insights

  • Trends Transforming the Healthcare Value Chain
  • Strategies Driving Biopharma Evolution

Appendix

  • Patent Analysis
  • Patent Analysis
  • Industry Interactions
  • Industry Interactions
This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across emerging business models in the biopharmaceutical industry. The corresponding patent scenario is depicted, along with the industry interactions.. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Biopharma, proof of concept model, lean innovation model, outcome focused model, collaborative business model
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D951-00-07-00-00
Is Prebook No
Ti Codes D951